Form4insider filings, from the source

SEC Form 4 · accession 0001493152-16-010941

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ram Krishnan
Officer — CEO · Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 17, 2016 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 17, 2016P183$4.58A3,083D
Common StockJun 17, 2016P200$4.60A3,283D
Common StockJun 17, 2016P100$4.71A3,383D
Common StockJun 17, 2016P100$4.7199A3,483D
Common StockJun 17, 2016P20$4.72A3,503D
Common StockJun 17, 2016P100$4.83A3,603D
Common StockJun 17, 2016P1,100$4.85A4,703D
Common StockJun 17, 2016P100$4.94A4,803D
Common StockJun 17, 2016P200$4.95A5,003D
Common StockJun 17, 2016P300$4.97A5,303D
Common StockJun 17, 2016P597$4.9799A5,900D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses